3184 logo

MicroBase Technology Stock Price

Symbol: TPEX:3184Market Cap: NT$854.9mCategory: Healthcare

3184 Share Price Performance

NT$10.65
-3.30 (-23.66%)
NT$10.65
-3.30 (-23.66%)
Price NT$10.65

3184 Community Narratives

There are no narratives available yet.

Recent 3184 News & Updates

No updates

MicroBase Technology Corp. Key Details

NT$214.8m

Revenue

NT$94.4m

Cost of Revenue

NT$120.3m

Gross Profit

NT$50.9m

Other Expenses

NT$69.4m

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.86
Gross Margin
56.03%
Net Profit Margin
32.33%
Debt/Equity Ratio
3.0%

MicroBase Technology Corp. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About 3184

Founded
1997
Employees
n/a
CEO
Tian Lai Liu
WebsiteView website
microbasetech.com

MicroBase Technology Corp. provides drug delivery systems to patients and healthcare professionals in Taiwan. It develops non-silicon-based MEMS by using LIGA technology that could be applied in the manufacture and development of miniaturized devices and micron-scale parts. The company also offers Pocket Air, an inhalation devices for the treatment of respiratory diseases; and PharMatrix, a micro-needles products for women to use at home. MicroBase Technology Corp. was founded in 1997 and is based in Taoyuan City, Taiwan.

Taiwanese Market Performance

  • 7 Days: 0.1%
  • 3 Months: 13.7%
  • 1 Year: 8.7%
  • Year to Date: 2.1%
Over the last 7 days, the market has remained flat, although notably the Energy sector declined by 8.6%. More promisingly, the market is up 8.7% over the past year. Earnings are forecast to grow by 13% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading